Literature DB >> 24741043

Cannabis use is quantitatively associated with nucleus accumbens and amygdala abnormalities in young adult recreational users.

Jodi M Gilman1, John K Kuster, Sang Lee, Myung Joo Lee, Byoung Woo Kim, Nikos Makris, Andre van der Kouwe, Anne J Blood, Hans C Breiter.   

Abstract

Marijuana is the most commonly used illicit drug in the United States, but little is known about its effects on the human brain, particularly on reward/aversion regions implicated in addiction, such as the nucleus accumbens and amygdala. Animal studies show structural changes in brain regions such as the nucleus accumbens after exposure to Δ9-tetrahydrocannabinol, but less is known about cannabis use and brain morphometry in these regions in humans. We collected high-resolution MRI scans on young adult recreational marijuana users and nonusing controls and conducted three independent analyses of morphometry in these structures: (1) gray matter density using voxel-based morphometry, (2) volume (total brain and regional volumes), and (3) shape (surface morphometry). Gray matter density analyses revealed greater gray matter density in marijuana users than in control participants in the left nucleus accumbens extending to subcallosal cortex, hypothalamus, sublenticular extended amygdala, and left amygdala, even after controlling for age, sex, alcohol use, and cigarette smoking. Trend-level effects were observed for a volume increase in the left nucleus accumbens only. Significant shape differences were detected in the left nucleus accumbens and right amygdala. The left nucleus accumbens showed salient exposure-dependent alterations across all three measures and an altered multimodal relationship across measures in the marijuana group. These data suggest that marijuana exposure, even in young recreational users, is associated with exposure-dependent alterations of the neural matrix of core reward structures and is consistent with animal studies of changes in dendritic arborization.

Entities:  

Keywords:  cannabis; gray matter density; marijuana; multimodal imaging; reward; topology/shape

Mesh:

Year:  2014        PMID: 24741043      PMCID: PMC3988409          DOI: 10.1523/JNEUROSCI.4745-13.2014

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  56 in total

Review 1.  Voxel-based morphometry--the methods.

Authors:  J Ashburner; K J Friston
Journal:  Neuroimage       Date:  2000-06       Impact factor: 6.556

2.  Associations between cannabinoid receptor-1 (CNR1) variation and hippocampus and amygdala volumes in heavy cannabis users.

Authors:  Joseph P Schacht; Kent E Hutchison; Francesca M Filbey
Journal:  Neuropsychopharmacology       Date:  2012-06-06       Impact factor: 7.853

3.  Subjective and physiological effects after controlled Sativex and oral THC administration.

Authors:  E L Karschner; W D Darwin; R P McMahon; F Liu; S Wright; R S Goodwin; M A Huestis
Journal:  Clin Pharmacol Ther       Date:  2011-02-02       Impact factor: 6.875

Review 4.  Statistical shape models for 3D medical image segmentation: a review.

Authors:  Tobias Heimann; Hans-Peter Meinzer
Journal:  Med Image Anal       Date:  2009-05-27       Impact factor: 8.545

5.  Grey matter alterations associated with cannabis use: results of a VBM study in heavy cannabis users and healthy controls.

Authors:  Janna Cousijn; Reinout W Wiers; K Richard Ridderinkhof; Wim van den Brink; Dick J Veltman; Anna E Goudriaan
Journal:  Neuroimage       Date:  2011-09-29       Impact factor: 6.556

Review 6.  Structural MRI findings in long-term cannabis users: what do we know?

Authors:  Valentina Lorenzetti; Dan I Lubman; Sarah Whittle; Nadia Solowij; Murat Yücel
Journal:  Subst Use Misuse       Date:  2010-09       Impact factor: 2.164

7.  Structural abnormalities in gyri of the prefrontal cortex in individuals with schizophrenia and their unaffected siblings.

Authors:  Michael P Harms; Lei Wang; Carolina Campanella; Kristina Aldridge; Amanda J Moffitt; John Kuelper; J Tilak Ratnanather; Michael I Miller; Deanna M Barch; John G Csernansky
Journal:  Br J Psychiatry       Date:  2010-02       Impact factor: 9.319

8.  Microstructural abnormalities in subcortical reward circuitry of subjects with major depressive disorder.

Authors:  Anne J Blood; Dan V Iosifescu; Nikos Makris; Roy H Perlis; David N Kennedy; Darin D Dougherty; Byoung Woo Kim; Myung Joo Lee; Shirley Wu; Sang Lee; Jesse Calhoun; Steven M Hodge; Maurizio Fava; Bruce R Rosen; Jordan W Smoller; Gregory P Gasic; Hans C Breiter
Journal:  PLoS One       Date:  2010-11-29       Impact factor: 3.240

Review 9.  Neurocircuitry of addiction.

Authors:  George F Koob; Nora D Volkow
Journal:  Neuropsychopharmacology       Date:  2010-01       Impact factor: 7.853

10.  Volumetric and shape analysis of the thalamus in first-episode schizophrenia.

Authors:  Denise M Coscia; Katherine L Narr; Delbert G Robinson; Liberty S Hamilton; Serge Sevy; Katherine E Burdick; Handan Gunduz-Bruce; Joanne McCormack; Robert M Bilder; Philip R Szeszko
Journal:  Hum Brain Mapp       Date:  2009-04       Impact factor: 5.038

View more
  109 in total

1.  BOLD responses to inhibition in cannabis-using adolescents and emerging adults after 2 weeks of monitored cannabis abstinence.

Authors:  Alexander L Wallace; Kristin E Maple; Alicia T Barr; Krista M Lisdahl
Journal:  Psychopharmacology (Berl)       Date:  2020-07-26       Impact factor: 4.530

2.  Differential associations of combined vs. isolated cannabis and nicotine on brain resting state networks.

Authors:  Francesca M Filbey; Suril Gohel; Shikha Prashad; Bharat B Biswal
Journal:  Brain Struct Funct       Date:  2018-06-07       Impact factor: 3.270

3.  Recent Self-Reported Cannabis Use Is Associated With the Biometrics of Delta-9-Tetrahydrocannabinol.

Authors:  Matthew J Smith; Eva C Alden; Amy A Herrold; Andrea Roberts; Dan Stern; Joseph Jones; Allan Barnes; Kailyn P O'Connor; Marilyn A Huestis; Hans C Breiter
Journal:  J Stud Alcohol Drugs       Date:  2018-05       Impact factor: 2.582

4.  Associations between adolescent cannabis use and brain structure in psychosis.

Authors:  Hila Abush; Subroto Ghose; Erin A Van Enkevort; Brett A Clementz; Godfrey D Pearlson; John A Sweeney; Matcheri S Keshavan; Carol A Tamminga; Elena I Ivleva
Journal:  Psychiatry Res Neuroimaging       Date:  2018-03-28       Impact factor: 2.376

Review 5.  Cannabis effects on brain structure, function, and cognition: considerations for medical uses of cannabis and its derivatives.

Authors:  Alison C Burggren; Anaheed Shirazi; Nathaniel Ginder; Edythe D London
Journal:  Am J Drug Alcohol Abuse       Date:  2019-07-31       Impact factor: 3.829

6.  Sexual risk-taking and subcortical brain volume in adolescence.

Authors:  Sarah W Feldstein Ewing; Karen A Hudson; Justin Caouette; Andrew R Mayer; Rachel E Thayer; Sephira G Ryman; Angela D Bryan
Journal:  Ann Behav Med       Date:  2018-04-19

7.  Long-term effects of marijuana use on the brain.

Authors:  Francesca M Filbey; Sina Aslan; Vince D Calhoun; Jeffrey S Spence; Eswar Damaraju; Arvind Caprihan; Judith Segall
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-10       Impact factor: 11.205

8.  Adolescent Δ(9)-Tetrahydrocannabinol Exposure Alters WIN55,212-2 Self-Administration in Adult Rats.

Authors:  Maria Scherma; Christian Dessì; Anna Lisa Muntoni; Salvatore Lecca; Valentina Satta; Antonio Luchicchi; Marco Pistis; Leigh V Panlilio; Liana Fattore; Steven R Goldberg; Walter Fratta; Paola Fadda
Journal:  Neuropsychopharmacology       Date:  2015-09-21       Impact factor: 7.853

9.  Grey Matter Volume Differences Associated with Extremely Low Levels of Cannabis Use in Adolescence.

Authors:  Catherine Orr; Philip Spechler; Zhipeng Cao; Matthew Albaugh; Bader Chaarani; Scott Mackey; Deepak D'Souza; Nicholas Allgaier; Tobias Banaschewski; Arun L W Bokde; Uli Bromberg; Christian Büchel; Erin Burke Quinlan; Patricia Conrod; Sylvane Desrivières; Herta Flor; Vincent Frouin; Penny Gowland; Andreas Heinz; Bernd Ittermann; Jean-Luc Martinot; Marie-Laure Paillère Martinot; Frauke Nees; Dimitri Papadopoulos Orfanos; Tomáš Paus; Luise Poustka; Sabina Millenet; Juliane H Fröhner; Rajiv Radhakrishnan; Michael N Smolka; Henrik Walter; Robert Whelan; Gunter Schumann; Alexandra Potter; Hugh Garavan
Journal:  J Neurosci       Date:  2019-01-14       Impact factor: 6.167

Review 10.  Cannabinoids and Epilepsy.

Authors:  Evan C Rosenberg; Richard W Tsien; Benjamin J Whalley; Orrin Devinsky
Journal:  Neurotherapeutics       Date:  2015-10       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.